Enovis to Participate in Upcoming Investor Conferences
Enovis Corporation (NYSE: ENOV), a medical technology growth company, has announced its upcoming participation in three major investor conferences:
- Canaccord Genuity 45th Annual Growth Conference on August 13th at 8:30 a.m. ET
- Wells Fargo Healthcare Conference on September 3rd at 2:15 p.m. ET
- Baird 2025 Global Healthcare Conference on September 10th at 3:10 p.m. ET
Live audio webcasts and replays will be accessible through the Investors section of the company's website under Events and Presentations.
Enovis Corporation (NYSE: ENOV), un'azienda in crescita nel settore della tecnologia medica, ha annunciato la sua prossima partecipazione a tre importanti conferenze per investitori:
- Canaccord Genuity 45th Annual Growth Conference il 13 agosto alle 8:30 ET
- Wells Fargo Healthcare Conference il 3 settembre alle 14:15 ET
- Baird 2025 Global Healthcare Conference il 10 settembre alle 15:10 ET
Le trasmissioni audio in diretta e le registrazioni saranno disponibili nella sezione Investitori del sito web dell'azienda, nella pagina Eventi e Presentazioni.
Enovis Corporation (NYSE: ENOV), una empresa en crecimiento en tecnología médica, ha anunciado su próxima participación en tres importantes conferencias para inversores:
- Canaccord Genuity 45th Annual Growth Conference el 13 de agosto a las 8:30 a.m. ET
- Wells Fargo Healthcare Conference el 3 de septiembre a las 2:15 p.m. ET
- Baird 2025 Global Healthcare Conference el 10 de septiembre a las 3:10 p.m. ET
Las retransmisiones de audio en vivo y las repeticiones estarán disponibles en la sección de Inversores del sitio web de la compañía, bajo Eventos y Presentaciones.
Enovis Corporation (NYSE: ENOV)는 의료 기술 성장 기업으로, 다음 세 가지 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다:
- Canaccord Genuity 45th Annual Growth Conference 8월 13일 오전 8:30 ET
- Wells Fargo Healthcare Conference 9월 3일 오후 2:15 ET
- Baird 2025 Global Healthcare Conference 9월 10일 오후 3:10 ET
라이브 오디오 웹캐스트 및 재방송은 회사 웹사이트의 투자자 섹션 내 이벤트 및 프레젠테이션 페이지에서 이용할 수 있습니다.
Enovis Corporation (NYSE: ENOV), une entreprise en croissance dans le domaine des technologies médicales, a annoncé sa prochaine participation à trois grandes conférences pour investisseurs :
- Canaccord Genuity 45th Annual Growth Conference le 13 août à 8h30 ET
- Wells Fargo Healthcare Conference le 3 septembre à 14h15 ET
- Baird 2025 Global Healthcare Conference le 10 septembre à 15h10 ET
Les webcasts audio en direct et les rediffusions seront accessibles dans la section Investisseurs du site web de l'entreprise, sous Événements et Présentations.
Enovis Corporation (NYSE: ENOV), ein wachstumsorientiertes Medizintechnikunternehmen, hat seine bevorstehende Teilnahme an drei wichtigen Investorenkonferenzen angekündigt:
- Canaccord Genuity 45th Annual Growth Conference am 13. August um 8:30 Uhr ET
- Wells Fargo Healthcare Conference am 3. September um 14:15 Uhr ET
- Baird 2025 Global Healthcare Conference am 10. September um 15:10 Uhr ET
Live-Audio-Webcasts und Wiederholungen sind im Investor-Bereich der Unternehmenswebsite unter Veranstaltungen und Präsentationen verfügbar.
- None.
- None.
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
- Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13th at 8:30 a.m. Eastern Time.
- Wells Fargo Healthcare Conference on Wednesday, September 3rd at 2:15 p.m. Eastern Time.
- Baird 2025 Global Healthcare Conference on Wednesday, September 10th at 3:10 p.m. Eastern Time.
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
When is Enovis (ENOV) presenting at the Canaccord Genuity Growth Conference 2025?
How can investors access Enovis (ENOV) conference presentations in August and September 2025?
What investor conferences will Enovis (ENOV) attend in 2025?
What time is Enovis (ENOV) presenting at the Wells Fargo Healthcare Conference 2025?
